Healthscape Advisors, LLC – Trademark Portfolio
Entity Type: 16
Healthscape Advisors, LLC holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 6 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include HEALTHSCAPE ADVISORS. The owner is based in Chicago, IL.
55 West Monroe Street, Suite 2100
Chicago, IL 60603
Showing of trademarks Trademarks
Trademark Classifications
Healthscape Advisors, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Healthscape Advisors, LLC have?
Healthscape Advisors, LLC has 10 U.S. trademarks filed with the USPTO. Of these, 3 registered, 4 abandoned, 3 cancelled.
What trademark classes does Healthscape Advisors, LLC file in?
Healthscape Advisors, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 35 (Advertising & Business), Class 42 (Computer & Scientific). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are Healthscape Advisors, LLC's most well-known trademarks?
Healthscape Advisors, LLC's registered trademark portfolio includes well-known marks such as HEALTHSCAPE ADVISORS. These are among 3 currently registered trademarks in the portfolio.
What is Healthscape Advisors, LLC's trademark registration success rate?
Healthscape Advisors, LLC has a 30% trademark registration rate, with 3 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.